The thermal expansion of a Kevlar® 49 cord down to cryogenic temperatures

In this work the thermal expansion of a twisted Kevlar® 49 cord assembly made at SRON in the 293 K to 7 K temperature range is presented. In addition to these results, the setup used to measure this thermal expansion is described, as are the methods used to calibrate and verify the accuracy of this setup. Measurements with the set-up agree to within 5 % with Ti-6Al-4V literature values. The thermal expansion of the SRON Kevlar® 49 cord assembly is measured and compared to the sparse literature available. At 7 K, the total fractional expansion of the Kevlar® cord assembly is 1.6·10-3 relative to 293 K, with an estimated relative error of 3%.</p

Design and validation of a large-format transition edge sensor array magnetic shielding system for space application

The paper describes the development and the experimental validation of a cryogenic magnetic shielding system for transition edge sensor based space detector arrays. The system consists of an outer mu-metal shield and an inner superconducting niobium shield. First, a basic comparison is made between thin-walled mu-metal and superconducting shields, giving an off-axis expression for the field inside a cup-shaped superconductor as a function of the transverse external field. Starting from these preliminary analytical considerations, the design of an adequate and realistic shielding configuration for future space flight applications (either X-IFU [D. Barret et al., e-print arXiv:1308.6784 [astro-ph.IM] (2013)] or SAFARI [B. Jackson et al., IEEE Trans. Terahertz Sci. Technol. 2, 12 (2012)]) is described in more detail. The numerical design and verification tools (static and dynamic finite element method (FEM) models) are discussed together with their required input, i.e., the magnetic-field dependent permeability data. Next, the actual manufacturing of the shields is described, including a method to create a superconducting joint between the two superconducting shield elements that avoid flux penetration through the seam. The final part of the paper presents the experimental verification of the model predictions and the validation of the shield's performance. The shields were cooled through the superconducting transition temperature of niobium in zero applied magnetic field (<10 nT) or in a DC field with magnitude ∼100 μT, applied either along the system's symmetry axis or perpendicular to it. After cool-down, DC trapped flux profiles were measured along the shield axis with a flux-gate magnetometer and the attenuation of externally applied AC fields (100 μT, 0.1 Hz, both axial and transverse) was verified along this axis with superconducting quantum interference device magnetometers. The system's measured on-axis shielding factor is greater than 106, well exceeding the requirement of the envisaged missions. Following field-cooling in an axial field of 85 μT, the residual internal DC field normal to the detector plane is less than 1 μT. The trapped field patterns are compared to the predictions of the dynamic FEM model, which describes them well in the region where the internal field exceeds 6 μT

Reconstructing the human hematopoietic niche in immunodeficient mice: Opportunities for studying primary multiple myeloma

Interactions within the hematopoietic niche in the BM microenvironment are essential for maintenance of the stem cell pool. In addition, this niche is thought to serve as a sanctuary site for malignant progenitors during chemotherapy. Therapy resistance induced by interactions with the BM microenvironment is a major drawback in the treatment of hematologic malignancies and bone-metastasizing solid tumors. To date, studying these interactions was hampered by the lack of adequate in vivo models that simulate the human situation. In the present study, we describe a unique human-mouse hybrid model that allows engraftment and outgrowth of normal and malignant hematopoietic progenitors by implementing a technology for generating a human bone environment. Using luciferase gene marking of patient-derived multiple myeloma cells and bioluminescent imaging, we were able to follow pMM cells outgrowth and to visualize the effect of treatment. Therapeutic interventions in this model resulted in equivalent drug responses as observed in the corresponding patients. This novel human-mouse hybrid model creates unprecedented opportunities to investigate species-specific microenvironmental influences on normal and malignant hematopoietic development, and to develop and personalize cancer treatment strategies